1. Clinical trials on new drugs (including vaccines) are designed to report desired outcomes.
2. Clinical trials are conducted for a year or less (sometimes as short as 6 weeks)
3. New drugs are fast-tracked through the FDA
4. FDA approves and drugs are released to medical consumers
5. Medical consumers believe the marketing campaigns and buy the drugs
6. Medical consumers develop ‘new medical conditions’
7. Adversely injured go to doctors who tell them ‘It’s all in your head.’
8. Medical consumers turn to social media and find out hundreds and thousands of others have been adversely injured
9. Adversely injured go to doctors who tell them ‘It’s all in your head.’ But take these other drugs to help.
10. Adversely injured go to doctors who tell them ‘It’s all in your head.’ Say new drugs are not helping. Doctor says see a psychiatrist.
11. Medical industry profits from diagnostic testing and procedures
12. Five to 10 years after drug is introduced to the market independent studies are conducted on safety and efficacy.
13. Study findings show drug is potentially dangerous and ineffective
14. Manufacturer changes patent on drug (usually one molecule configuration).
15. Re-patents, repackages and finds another use for said drug; initiates a new marketing campaign
16. Eventually, after hundreds of thousand injuries and deaths the drug comes off the market. But not until pharma and the government have made their profit.
You do the hokey-pokey and you turn yourself around – that’s what its all about.
Study Reveals “Unavoidable” Danger of HPV Vaccines
Monday, February 17th 2014 at 6:00 am
A new review published in Autoimmunity Reviews titled, “On the relationship between human papilloma virus vaccine and autoimmune disease,” is destined to reopen the controversy surrounding numerous reports of HPV vaccine-induced harm that have surfaced ever since their widespread use, beginning with the FDA’s 2006 approval of Merck & Co.’s Gardasil.[i]
The study points out, “Along with the introduction of the HPV vaccines, several cases of onset or exacerbations of autoimmune diseases following the vaccine shot have been reported in the literature and pharmacovigilance databases, triggering concerns about its safety.”
Following an extensive review of the biomedical literature, they listed conditions in which HPV vaccination is most likely linked to the development of autoimmune diseases (with qualification that they are only raising possible links and not fully confirmed ones), including:
- Acute disseminated encephalomyelitis and other demyelinating diseases of the central nervous system
- Multiple sclerosis (MS)
- Guillain–Barré syndrome (GBS)
- Primary ovarian failure (POF)
- IgA bullosus dermatitis
- Henoch-Schonlein purpura
- Cutaneous vasculitis
- Kikuch-Fujimoto disease
- Erythema multiforme
- Acute cerebral ataxia
- Immune thrombocytopenic purpura
The authors caution that, “The decision to vaccinate with HPV vaccine is a personal decision, not one that must be made for public health. HPV is not a lethal disease in 95% of the infections; and the other 5% are detectable and treatable in the precancerous stage.”